Vaccine makers Pfizer and Moderna pledge massive boost to U.S. supply after sluggish rollout

The increases needed to meet March delivery targets will be steep, however, and Biden administration officials expect the companies could come up slightly short.

Source: Washington Post: To Your Health - February 23, 2021 Category: Consumer Health News Authors: Isaac Stanley-Becker Source Type: news